U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT06930144) titled '5-MTHF Supplementation for Treatment of Type 1 Diabetes Patients' on April 08.
Brief Summary: This study aims to evaluate the improvement of autoimmune status in patients with Type 1 Diabetes (T1D) through supplementation with 5-Methyltetrahydrofolate, and to explore the safety and efficacy of this treatment. The research seeks to provide new methods for the treatment of T1D and offer innovative ideas for enhancing the quality of life of T1D patients.
Study Start Date: April, 2025
Study Type: INTERVENTIONAL
Condition:
Type 1 Diabetes Mellitus
Intervention:
DRUG: active folate
Daily oral intake of active folate 800ug combined...